ALGS – aligos therapeutics, inc. - common stock (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ALGS

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/9

06:10 am

algs

Aligos Therapeutics (NASDAQ:ALGS) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.

High Report

Aligos Therapeutics (NASDAQ:ALGS) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.

Report

1/7

03:11 pm

algs

Rating for ALGS

Medium Report

Rating for ALGS

Report

1/7

08:16 am

algs

Aligos Therapeutics initiated with a Buy at UBS

High Report

Aligos Therapeutics initiated with a Buy at UBS

Report

1/7

03:00 am

algs

Aligos Therapeutics (NASDAQ:ALGS) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.

High Report

Aligos Therapeutics (NASDAQ:ALGS) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.